Literature DB >> 8601593

Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.

P Koolwijk1, M G van Erck, W J de Vree, M A Vermeer, H A Weich, R Hanemaaijer, V W van Hinsbergh.   

Abstract

In angiogenesis associated with tissue repair and disease, fibrin and inflammatory mediators are often involved. We have used three-dimensional fibrin matrices to investigate the humoral requirements of human microvascular endothelial cells (hMVEC) to form capillary-like tubular structures. bFGF and VEGF165 were unable to induce tubular structures by themselves. Simultaneous addition of one or both of these factors with TNFalpha induced outgrowth of tubules, the effect being the strongest when bFGF, VEGF165, and TNFalpha were added simultaneously. Exogenously added u-PA, but not its nonproteolytic amino-terminal fragment, could replace TNFalpha, suggesting that TNFalpha-induced u-PA synthesis was involved. Soluble u-PA receptor (u-PAR) or antibodies that inhibited u-PA activity prevented the formation of tubular structures by 59-99%. epsilon-ACA and trasylol which inhibit the formation and activity of plasmin reduced the extent of tube formation by 71-95%. TNFalpha or u-PA did not induce tubular structures without additional growth factors. bFGF and VEGF165 enhanced of the u-PAR by 72 and 46%, but TNFalpha itself also increased u-PAR in hMVEC by 30%. Induction of mitogenesis was not the major contribution of bFGF and VEGF165 because the cell number did not change significantly in the presence of TNFalpha, and tyrphostin A47, which inhibited mitosis completely, reduced the formation of tubular structures only by 28-36%. These data show that induction of cell-bound u-PA activity by the cytokine TNFalpha is required in addition to the angiogenic factors VEGF165 and/or bFGF to induce in vitro formation of capillary-like structures by hMVEC in fibrin matrices. These data may provide insight in the mechanism of angiogenesis as occurs in pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601593      PMCID: PMC2120755          DOI: 10.1083/jcb.132.6.1177

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  56 in total

Review 1.  Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair.

Authors:  J A Madri; L Bell; M Marx; J R Merwin; C Basson; C Prinz
Journal:  J Cell Biochem       Date:  1991-02       Impact factor: 4.429

Review 2.  Regulators of angiogenesis.

Authors:  M Klagsbrun; P A D'Amore
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

3.  Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression.

Authors:  N K Rao; G P Shi; H A Chapman
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.

Authors:  A Bikfalvi; C Sauzeau; H Moukadiri; J Maclouf; N Busso; M Bryckaert; J Plouet; G Tobelem
Journal:  J Cell Physiol       Date:  1991-10       Impact factor: 6.384

5.  Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages.

Authors:  S S Gross; E A Jaffe; R Levi; R G Kilbourn
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

6.  Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells.

Authors:  P Defilippi; G Truffa; G Stefanuto; F Altruda; L Silengo; G Tarone
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

7.  Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.

Authors:  M S Pepper; N Ferrara; L Orci; R Montesano
Journal:  Biochem Biophys Res Commun       Date:  1991-12-16       Impact factor: 3.575

8.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

Authors:  V Ellis; N Behrendt; K Danø
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

9.  Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.

Authors:  P Mignatti; R Mazzieri; D B Rifkin
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

10.  Differential distribution and modulation of expression of alpha 1/beta 1 integrin on human endothelial cells.

Authors:  P Defilippi; V van Hinsbergh; A Bertolotto; P Rossino; L Silengo; G Tarone
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  51 in total

Review 1.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

Authors:  Alexander Kapustin; Victoria Stepanova; Natalia Aniol; Douglas B Cines; Alexei Poliakov; Serge Yarovoi; Tatiana Lebedeva; Robin Wait; Grigory Ryzhakov; Yelena Parfyonova; Yaroslav Gursky; Hiromi Yanagisawa; Mikhail Minashkin; Robert Beabealashvilli; Alexander Vorotnikov; Alex Bobik; Vsevolod Tkachuk
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

3.  Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer.

Authors:  Shun Kobayashi; Noriko Nakajima; Yoko Ito; Mitsuhiko Moriyama
Journal:  J Gastroenterol       Date:  2010-03-24       Impact factor: 7.527

4.  Engineered microvessels with strong alignment and high lumen density via cell-induced fibrin gel compaction and interstitial flow.

Authors:  Kristen T Morin; Jessica L Dries-Devlin; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2013-11-14       Impact factor: 3.845

5.  Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.

Authors:  E M Paleolog; R A Fava
Journal:  Springer Semin Immunopathol       Date:  1998

Review 6.  Current concepts of tumor-induced angiogenesis.

Authors:  S Paku
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  A cell-based model of extracellular-matrix-guided endothelial cell migration during angiogenesis.

Authors:  Josephine T Daub; Roeland M H Merks
Journal:  Bull Math Biol       Date:  2013-03-15       Impact factor: 1.758

8.  Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.

Authors:  N N Nissen; P J Polverini; A E Koch; M V Volin; R L Gamelli; L A DiPietro
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?

Authors:  K L Rensing; F M Houttuijn Bloemendaal; E M Weijers; D J Richel; H R Büller; P Koolwijk; C M van der Loos; Th B Twickler; J H von der Thüsen
Journal:  Diabetologia       Date:  2010-02-25       Impact factor: 10.122

10.  Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix.

Authors:  Nancy Laurens; Marten A Engelse; Clarissa Jungerius; Clemens W Löwik; Victor W M van Hinsbergh; Pieter Koolwijk
Journal:  Angiogenesis       Date:  2009-05-16       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.